Genentech

KADCYLA

Manufacturer:

Genentech

Kadcyla HCPCS:

J9354

HCPCS Code Descriptor:

Injection, ado-trastuzumab emtansine, 1 mg

Category:

J Code

Kadcyla NDCs:

50242-0087-01, 50242-0088-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Kadcyla:

KADCYLA is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9354 is aligned to the drug KADCYLA.

ACCESS PRICING AND MORE BY REGISTERING

J9354 Added Date:

January 1, 2014

J9354 Effective Date:

January 1, 2014

J9354 Termination Date:

HCPCS Active

Kadcyla billing and coding information can be found through Genentech at the link below:
Kadcyla patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-foundation
KADCYLA prescribing information can be found at the link below:
Information regarding KADCYLA’s side effects can be found at MedlinePlus